相关实验视频
Updated: May 5, 2026

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
7.5K
[塔罗·奥卡莫托和帕金森病]
1Department of General Internal Medicine, National Center of Neurology and Psychiatry (NCNP) National Center Hospital.
Brain and nerve = Shinkei kenkyu no shinpo
|December 5, 2024
概括
这项研究探讨了抗帕金森症药物如何影响艺术家塔罗·奥卡莫托 (Taro Okamoto) 在帕金森病期间的创造力. 它检查了他的艺术焦点的变化,并讨论了他的死亡原因.
科学领域:
- 艺术史 艺术史 艺术史
- 神经学 神经学
- 医学人文学科 医学人文学科
背景情况:
- 帕金森病 (PD) 影响运动和非运动功能,影响全球个人.
- 著名的日本艺术家塔罗·奥卡莫托 (Taro Okamoto) 在晚年发展了PD,经历了面部pareidolia.
- 与PD相关的视力障碍,包括色彩视力缺陷和对比度敏感性降低,影响了Okamoto的艺术作品.
研究的目的:
- 为了调查抗帕金森症药物对塔罗·奥卡莫托创作过程的影响.
- 分析他艺术媒介从绘画转向陶和雕塑的转变.
- 讨论导致他死亡的急性呼吸衰竭的病因.
主要方法:
- 对Okamoto的艺术作品和个人记录进行了定性分析.
- 对帕金森病及其对创造力影响的医学文献的综述.
- 检查抗帕金森病药物的药理作用.
主要成果:
- 抗帕金森症药物可能调节了Okamoto的感知和创造性表达.
- 这项研究将他的视觉感知变化与他的艺术媒介过渡相关联.
- 面部 pareidolia 影响了他的"面孔玻璃"概念.
结论:
- 抗帕金森症药物可能影响了奥卡莫托的艺术轨迹.
- 了解神经疾病,药物和创造力之间的相互作用,为艺术适应提供了洞察力.
- 这项研究强调了神经疾病和艺术成果之间的复杂关系.
相关概念视频
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163
Narcolepsy
89
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
89
Panic Disorder
38
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
38

